Advertisement
Screener

Cumberland Pharmaceuticals Inc. (CPIX) Graph

CPIX Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Revenue (m); Cost of revenue (m); Research and development $772.16K; Income tax $3.87K.
  • 2026-03-31: Revenue $9.13M; Cost of revenue $1.93M; Research and development $1.46M; Income tax $3.87K.
  • 2025-12-31: Revenue $13.68M; Cost of revenue $2.24M*; Research and development $1.55M*; Income tax $23.25K*.
  • 2025-09-30: Revenue $8.29M; Cost of revenue $988.76K; Research and development $1.25M; Income tax $5.67K.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2026-06-30(m)(m)$772.16K$3.87K-$4.28M
2026-03-31$9.13M$1.93M$1.46M$3.87K-$3.29M
2025-12-31$13.68M$2.24M*$1.55M*$23.25K*-$1.41M
2025-09-30$8.29M$988.76K$1.25M$5.67K-$1.94M
2025-06-30(m)$2.01M$837.40K$5.67K-$740.74K
2025-03-31$11.71M$1.43M$1.30M$5.67K$1.26M
2024-12-31$10.44M(m)(m)(m)-$1.90M
2024-09-30$9.09M$1.32M$1.31M$11.44K-$1.54M
2024-06-30$9.85M$1.71M$1.06M$11.44K-$1.09M
2024-03-31$8.50M$1.58M$1.16M$11.44K-$1.95M
2023-12-31$9.35M(m)(m)(m)-$6.29M
2023-09-30$10.09M$1.77M$1.92M$6.94K-$1.05M
2023-06-30$10.89M$1.52M$1.15M$6.94K$872.20K
2023-03-31$9.22M$1.25M$1.50M$6.94K$192.18K
2022-12-31$9.12M(m)(m)(m)-$2.44M
2022-09-30$11.41M$2.22M$1.71M$6.90K-$408.64K
2022-06-30$10.30M$2.03M$1.82M$6.90K-$1.34M
2022-03-31$11.18M$2.21M$1.75M$6.90K-$1.39M
2021-12-31$8.32M(m)(m)(m)-$3.85M
2021-09-30$8.07M$1.33M$1.45M$7.46K-$1.06M
2021-06-30$9.06M$1.74M$1.36M$7.46K$1.23M
2021-03-31$10.54M$2.42M$1.26M$7.46K$166.83K
2020-12-31$10.26M(m)(m)(m)-$883.78K
2020-09-30$9.25M$2.14M$1.23M$3.73K-$481.74K
2020-06-30$9.60M$2.61M$1.42M$7.46K-$918.27K
2020-03-31$8.33M$1.63M$1.72M$34.24K-$1.06M
2019-12-31$9.31M(m)(m)(m)-$960.71K
2019-09-30$6.94M$1.58M$1.67M$4.46K-$1.95M
2019-06-30$9.42M$1.79M$1.72M$4.46K-$549.51K
2019-03-31$8.73M$1.66M$1.40M-$81.43K-$73.88K
2018-12-31$10.49M(m)(m)(m)-$2.22M
2018-09-30$5.85M$1.46M$1.31M$4.16K-$1.64M
2018-06-30$7.08M$1.52M$1.45M$4.16K-$720.69K
2018-03-31$5.92M$1.53M$1.87M$4.16K-$2.38M
2017-12-31$11.65M(m)(m)(m)-$800.54K
2017-09-30$11.20M$2.17M$943.16K$3.82K-$743.03K
2017-06-30$8.67M(m)$1.08M$3.54M-$5.16M
2017-03-31$9.64M(m)$898.36K-$656.59K-$1.27M
2016-12-31$9.08M(m)(m)(m)-$749.69K
2016-09-30$8.79M(m)$644.66K$57.19K$106.17K
2016-06-30$7.41M(m)$678.78K-$41.13K-$48.04K
2016-03-31$7.74M(m)$706.47K-$175.34K-$253.11K
2015-12-31$8.04M(m)(m)(m)$151.06K
2015-09-30$7.89M(m)$757.44K$193.44K$126.61K
2015-06-30$8.91M(m)$828.07K$318.99K$407.40K
2015-03-31$8.69M(m)$1.86M$18.46K$46.28K
2014-12-31$9.33M(m)(m)(m)$668.91K
2014-09-30$9.73M(m)$934.78K$340.98K$745.92K
2014-06-30$9.75M(m)$861.15K$523.34K$722.57K
2014-03-31$8.09M(m)$826.37K$188.01K$286.32K
2013-12-31$8.16M(m)(m)(m)-$1.50M
2013-09-30$6.53M(m)$1.44M-$686.21K-$819.94K
2013-06-30$7.08M(m)$1.39M-$463.41K-$639.02K
2013-03-31$10.26M(m)$1.45M$559.37K$854.71K
2012-12-31$13.70M(m)(m)(m)$1.81M
2012-09-30$12.53M(m)$1.70M$1.21M$1.87M
2012-06-30$12.37M(m)$1.55M$263.03K$1.74M
2012-03-31$10.26M(m)$1.40M$282.03K$423.21K
2011-12-31$13.03M(m)(m)(m)$911.66K
2011-09-30$13.05M(m)$1.23M$1.28M$1.85M
2011-06-30$14.39M(m)$1.03M$1.44M$2.18M
2011-03-31$10.67M(m)$1.01M$523.58K$721.16K
2010-09-30$12.19M(m)$1.14M$943.14K$1.01M
2010-06-30$10.74M(m)$1.03M$374.46K$287.30K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2026-06-30(m)(m)$1.54M$7.74K-$7.57M
2025-06-30(m)$3.44M$1.52M$11.34K$516.33K
2024-06-30$18.35M$3.29M$2.22M$22.89K-$3.03M
2023-06-30$20.11M$2.77M$2.64M$13.88K$1.06M
2022-06-30$21.47M$4.24M$3.57M$13.80K-$2.72M
2021-06-30$19.59M$4.16M$2.62M$14.92K$1.40M
2020-06-30$17.93M$4.24M$3.14M$41.70K-$1.97M
2019-06-30$18.15M$3.45M$3.12M-$76.97K-$623.38K
2018-06-30$18.75M$3.05M$3.33M$8.32K-$3.10M
2017-06-30$18.30M(m)$1.98M$4.19M-$6.44M
2016-06-30$15.15M(m)$1.39M-$216.47K-$301.15K
2015-06-30$17.60M(m)$2.69M$337.45K$452.28K
2014-06-30$17.84M(m)$1.69M$711.35K$1.01M
2013-06-30$17.34M(m)$2.84M$95.96K$215.69K
2012-06-30$22.62M(m)$2.96M$545.06K$2.17M
2011-06-30$25.06M(m)$2.04M$1.96M$2.90M
2010-06-30$20.87M(m)$1.81M$586.20K$610.88K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-09-30$30.84M$4.43M$4.02M$17.01K-$1.42M
2024-09-30$27.43M$4.61M$3.52M$34.33K-$4.58M
2023-09-30$30.20M$4.54M$4.57M$20.81K$15.09K
2022-09-30$32.89M$6.47M$5.28M$20.70K-$3.13M
2021-09-30$27.67M$5.49M$4.07M$22.38K$340.11K
2020-09-30$27.18M$6.39M$4.37M$45.42K-$2.46M
2019-09-30$25.08M$5.03M$4.79M-$72.50K-$2.58M
2018-09-30$27.24M$4.51M$4.63M$12.48K-$4.74M
2017-09-30$29.50M$5.22M$2.92M$4.20M-$7.18M
2016-09-30$23.94M(m)$2.03M-$159.28K-$194.99K
2015-09-30$25.48M(m)$3.44M$530.88K$580.29K
2014-09-30$27.57M(m)$2.62M$1.05M$1.75M
2013-09-30$23.87M(m)$4.28M-$590.25K-$604.25K
2012-09-30$35.15M(m)$4.65M$1.75M$4.04M
2011-09-30$38.11M(m)$3.27M$3.24M$4.75M
2010-09-30$33.06M(m)$2.95M$1.53M$1.62M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-12-31$44.52M$6.67M$5.57M$40.26K-$2.84M
2024-12-31$37.87M$6.59M$4.82M-$22.67K-$6.48M
2023-12-31$39.55M$6.07M$5.83M$45.77K-$6.28M
2022-12-31$42.01M$9.12M$6.69M$68.85K-$5.57M
2021-12-31(m)$8.81M$5.68M$34.89K-$3.51M
2020-12-31(m)$8.65M$5.77M$55.90K-$3.34M
2019-12-31(m)$7.42M$6.87M-$79.32K-$3.54M
2018-12-31(m)$6.02M$7.58M$16.64K-$6.96M
2017-12-31(m)$5.42M$4.25M$4.17M-$7.98M
2016-12-31(m)$5.96M$3.19M-$330.92K-$944.68K
2015-12-31(m)(m)$3.85M$575.83K$731.35K
2014-12-31(m)(m)$3.39M$1.38M$2.42M
2013-12-31(m)(m)$5.62M-$1.52M-$2.10M
2012-12-31(m)(m)$5.10M$3.24M$5.84M
2011-12-31$51.14M(m)$5.03M$4.08M$5.66M
2010-12-31$45.88M(m)$4.33M$2.85M$2.46M
2009-12-31$43.54M(m)$4.99M$2.02M$3.09M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31